Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from the National Institute for Health and Care Excellence

Why raising NHS spending on new drugs by 25% is the wrong decision – health economist’s view

For nearly three decades, decisions about which medicines the NHS pays for have not been made by ministers, but by the National Institute for Health and Care Excellence, known as Nice. Its job has been powerful: to act as a check on the pharmaceutical industry by demanding evidence that new…

The Conversation

New cancer treatment could prevent patients needing ‘devastating’ surgery

The treatment, known as Papillon, could allow patients with rectal cancer to avoid the need for a stoma

The Independent UK

‘Important moment’ as at-home heart treatment approved for NHS use

About 1,500 patients in England and Wales live with the rare heart condition

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Game-changing’ HIV jab to be offered in England and Wales

The rollout is expected to begin around three months after Nice publishes its final guidance later this year

The Independent UK

‘Game-changing’ HIV prevention jab to be offered in England and Wales

The National Institute for Health and Care Excellence recommended the injection for people at risk of HIV who are unable to take oral PrEP.

Evening Standard

Type 2 diabetes patients set for major shake-up in care

New draft guidance from the National Institute for Health and Care Excellence suggests the NHS should move away from a one-size-fits-all approach.

The Independent UK

Heart patients to be offered rehab online under new draft guidance

The six platforms have been conditionally recommended in new draft guidance from the National Institute for Health and Care Excellence.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Drug that slows onset of type 1 diabetes licensed for use in UK-first

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

Evening Standard

Breakthrough drug that slows onset of type 1 diabetes set for UK release

Teplizumab can allow patients to live “normal lives” without the need for insulin injections

The Independent UK

Warning issued to patients who stop using weight-loss jabs

Health experts are calling for further help for those on the injections

The Independent UK

Weight-loss jabs linked to hundreds of cases of life-threatening illness and 10 deaths

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute and chronic pancreatitis among people taking them, figures from the UK’s medicines regulator reveal

The Independent UK

Weight-loss drugs among breakthrough trials offering ‘hope’ for dementia prevention

One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia

The Independent UK

Voices: The near-2.5m Brits with ADHD are not making it up

COMMENT: As the NHS releases the first official figures about the number of Britons with ADHD, Kat Brown writes that the way we disparage what we don't understand reflects both on our own fear and lack of literacy – and the irresponsible way we stigmatise wider disabled society

The Independent UK

Endometriosis: daily pill to manage symptoms will soon be available on the NHS – here’s how linzagolix works

A daily pill to treat endometriosis has just been recommended by the National Institute for Health and Care Excellence (Nice). Once available on the NHS, linzagolix will provide a new treatment option for those who have been unable to manage the condition using other standard treatments.

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

New treatment for advanced blood cancer recommended for use on NHS

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for Health and Care Excellence.

The Independent UK

Women with menopause symptoms ‘should be offered HRT as first treatment’

The National Institute for Health and Care Excellence announced the changes

Evening Standard

Hundreds of blood cancer patients to benefit from new treatment

Elranatamab, an injection that treats myeloma, has been recommended for NHS use by the National Institute for Health and Care Excellence.

The Independent UK

Donanemab: What is the new Alzheimer’s drug rejected for use on the NHS

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research

Get all your
news in one place.

100's of premium titles.
One news app.

GoodToKnow

Struggling to get a child ADHD diagnosis? New NHS test expected to be speedier for millions of kids

The National Institute for Health and Care Excellence believes the test will speed up getting diagnoses for children as young as six

The Independent UK

Landmark sickle cell drug axed by regulators

Exclusive: Crizanlizumab was hailed as first new drug to be introduced in over 20 years for people living with sickle cell disease

Chronicle Live

How the new 'game-changing' weight loss drug works, who is eligible and when it will be available in UK

The National Institute for Health and Care Excellence gave approval for the use of appetite suppressant Wegovy (semaglutide) earlier this year - here are more details about it

Nottingham Post

Eamonn Holmes among 28 million suffering in 'silent epidemic' pain

The National Institute for Health and Care Excellence (NICE), The British Pain Society (BPS) have dubbed the illness a silent epidemic

The Independent UK

Thousands could get new pill to combat migraines on the NHS

The National Institute for Health and Care Excellence’s draft guidance published on Wednesday recommended the drug Rimegepant as an option

The Independent UK

Thousands of people could get new pill to combat migraines

The National Institute for Health and Care Excellence’s draft guidance published on Wednesday recommended the drug Rimegepant as an option.

The Guardian - UK

Male GPs in England less likely to refer patients for IVF, report finds

Survey shows wide discrepancies between Nice guidelines and GP responses and ‘utter confusion’ on eligibility criteria

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

150 stories

Alnylam Pharmaceuticals

30 stories

the National Institute for Health and Care Excellence

27 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.